Sclerosis
MDPI AG · Switzerland
Aims & Scope
Subject areas: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system; Dermatology. Topics: sclerosis, atherosclerosis
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Sclerosis
Is Sclerosis a predatory journal?
PubScope has no integrity flags on record for Sclerosis: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Sclerosis?
Sclerosis is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is Sclerosis indexed in Scopus and Web of Science?
Sclerosis is indexed in DOAJ.
What is the aims and scope of Sclerosis?
Subject areas: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system; Dermatology. Topics: sclerosis, atherosclerosis
How much does it cost to publish in Sclerosis?
Sclerosis charges an article processing charge (APC) of about CHF 1,000 for open-access publication.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref